Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 13.30M | £ 42.30M | £ 68.10M | £ 183.60M | £ 4.30M |
Total Assets | £ 2.95B | £ 2.51B | £ 2.41B | £ 2.59B | £ 2.55B |
Total Debt | £ 979.40M | £ 626.50M | £ 623.00M | £ 779.10M | £ 613.20M |
Net Debt | £ 966.10M | £ 584.20M | £ 554.90M | £ 595.50M | £ 608.90M |
Total Liabilities | £ 1.08B | £ 712.30M | £ 723.30M | £ 874.10M | £ 703.50M |
Stockholders Equity | £ 1.88B | £ 1.80B | £ 1.69B | £ 1.72B | £ 1.84B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |